Abbott Laboratories Revenue 2010-2024 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending December 31, 2024 was $10.974B, a 7.16% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending December 31, 2024 was $41.950B, a 4.59% increase year-over-year.
  • Abbott Laboratories annual revenue for 2024 was $41.95B, a 4.59% increase from 2023.
  • Abbott Laboratories annual revenue for 2023 was $40.109B, a 8.12% decline from 2022.
  • Abbott Laboratories annual revenue for 2022 was $43.653B, a 1.34% increase from 2021.
Abbott Laboratories Annual Revenue
(Millions of US $)
2024 $41,950
2023 $40,109
2022 $43,653
2021 $43,075
2020 $34,608
2019 $31,904
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
Abbott Laboratories Quarterly Revenue
(Millions of US $)
2024-12-31 $10,974
2024-09-30 $10,635
2024-06-30 $10,377
2024-03-31 $9,964
2023-12-31 $10,241
2023-09-30 $10,143
2023-06-30 $9,978
2023-03-31 $9,747
2022-12-31 $10,091
2022-09-30 $10,410
2022-06-30 $11,257
2022-03-31 $11,895
2021-12-31 $11,468
2021-09-30 $10,928
2021-06-30 $10,223
2021-03-31 $10,456
2020-12-31 $10,701
2020-09-30 $8,853
2020-06-30 $7,328
2020-03-31 $7,726
2019-12-31 $8,314
2019-09-30 $8,076
2019-06-30 $7,979
2019-03-31 $7,535
2018-12-31 $7,765
2018-09-30 $7,656
2018-06-30 $7,767
2018-03-31 $7,390
2017-12-31 $7,589
2017-09-30 $6,829
2017-06-30 $6,637
2017-03-31 $6,335
2016-12-31 $5,333
2016-09-30 $5,302
2016-06-30 $5,333
2016-03-31 $4,885
2015-12-31 $5,188
2015-09-30 $5,150
2015-06-30 $5,170
2015-03-31 $4,897
2014-12-31 $5,356
2014-09-30 $5,079
2014-06-30 $5,057
2014-03-31 $4,755
2013-12-31 $4,008
2013-09-30 $4,825
2013-06-30 $5,446
2013-03-31 $5,378
2012-12-31 $3,188
2012-09-30 $5,265
2012-06-30 $5,313
2012-03-31 $5,284
2011-12-31 $10,377
2011-09-30 $9,817
2011-06-30 $9,616
2011-03-31 $9,041
2010-12-31 $9,968
2010-09-30 $8,675
2010-06-30 $8,826
2010-03-31 $7,698
2009-12-31 $8,790
2009-09-30 $7,761
2009-06-30 $7,495
2009-03-31 $6,718
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $222.392B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $154.781B 41.84
Stryker (SYK) United States $150.988B 32.49
EssilorLuxottica (ESLOY) France $128.761B 0.00
Medtronic (MDT) Ireland $116.457B 17.30
Lonza Group Ag (LZAGY) Switzerland $48.724B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
Agilent Technologies (A) United States $42.120B 27.91
GE HealthCare Technologies (GEHC) United States $40.456B 20.98
ResMed (RMD) United States $34.834B 26.83
Terumo (TRUMY) Japan $27.701B 39.39
Koninklijke Philips (PHG) Netherlands $25.801B 19.75
Zimmer Biomet Holdings (ZBH) United States $20.443B 12.84
Insulet (PODD) United States $20.179B 80.36
Baxter (BAX) United States $15.731B 10.24
Smith & Nephew SNATS (SNN) United Kingdom $11.039B 0.00
Sunny Optical Technology (SNPTF) China $9.976B 0.00
BellRing Brands (BRBR) United States $9.951B 37.15
Bio-Rad Laboratories (BIO) United States $9.670B 32.87
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $6.320B 14.69
Prestige Consumer Healthcare (PBH) United States $4.316B 20.65
ICU Medical (ICUI) United States $3.878B 36.92
Envista Holdings (NVST) United States $3.750B 29.85
Perrigo (PRGO) Ireland $3.407B 10.03
Haemonetics (HAE) United States $3.164B 14.89
GN Store Nord (GNNDY) Denmark $3.123B 21.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.832B 18.23
Neogen (NEOG) United States $2.315B 26.67
LeMaitre Vascular (LMAT) United States $2.245B 54.55
AtriCure (ATRC) United States $1.997B 0.00
Green Thumb Industries (GTBIF) United States $1.513B 26.48
AdaptHealth (AHCO) United States $1.300B 9.29
InMode (INMD) Israel $1.269B 10.61
Maravai LifeSciences Holdings (MRVI) United States $1.250B 0.00
BioLife Solutions (BLFS) United States $1.215B 0.00
Curaleaf Holdings (CURLF) Canada $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.996B 15.27
Evolus (EOLS) United States $0.849B 0.00
CeriBell (CBLL) United States $0.810B 0.00
Owens & Minor (OMI) United States $0.667B 5.21
Capricor Therapeutics (CAPR) United States $0.652B 0.00
VAREX IMAGING (VREX) United States $0.627B 27.14
Valneva SE (VALN) France $0.563B 0.00
Omeros (OMER) United States $0.526B 0.00
SNDL (SNDL) Canada $0.507B 0.00
Surmodics (SRDX) United States $0.487B 0.00
Cresco Labs (CRLBF) United States $0.474B 0.00
Verano Holdings (VRNOF) United States $0.424B 0.00
ZimVie (ZIMV) United States $0.383B 32.26
Canopy Growth (CGC) Canada $0.363B 0.00
Aurora Cannabis (ACB) Canada $0.343B 62.50
Cerus (CERS) United States $0.323B 0.00
Quanterix (QTRX) United States $0.320B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Sanara MedTech (SMTI) United States $0.309B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Biote (BTMD) United States $0.261B 5.73
Zynex (ZYXI) United States $0.252B 52.80
High Tide (HITI) Canada $0.238B 0.00
Sanuwave Health (SNWV) United States $0.232B 3.26
SEMPERIT AG HLD (SEIGY) Austria $0.226B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
TerrAscend (TSNDF) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.203B 15.16
Brainsway (BWAY) Israel $0.200B 106.40
MacroGenics (MGNX) United States $0.174B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.142B 17.83
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.101B 11.44
Exagen (XGN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.085B 0.00
InterCure (INCR) Israel $0.080B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
INLIF (INLF) $0.067B 0.00
Rockwell Medical (RMTI) United States $0.064B 33.00
Cytosorbents (CTSO) United States $0.057B 0.00
Ayr Wellness (AYRWF) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
MariMed (MRMD) United States $0.051B 0.00
United-Guardian (UG) United States $0.051B 14.60
Modular Medical (MODD) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00